awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26741620-35D0497A-4E0C-4D6C-9674-1EF8F88169DF
Q26741620-35D0497A-4E0C-4D6C-9674-1EF8F88169DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26741620-35D0497A-4E0C-4D6C-9674-1EF8F88169DF
Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials
P2860
Q26741620-35D0497A-4E0C-4D6C-9674-1EF8F88169DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26741620-35D0497A-4E0C-4D6C-9674-1EF8F88169DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10a3e80c0e3864e446e69625fce48442aa1f2f89
P2860
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.